Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Are the Projected Market Size and Growth Rates for the Pharmacogenetic Testing Market From 2025 To 2029?
The market size for pharmacogenetic testing has seen a swift expansion in recent years. It’s projected to escalate from $12.37 billion in 2024 to $14.33 billion in 2025, marking a compound annual growth rate (CAGR) of 15.8%. The historical growth trajectory is linked to several factors including an increase in overall drug effectiveness, rising acceptance of personalized medicine, a growing requirement for precision diagnosis, amplified focus on pharmacogenetic testing, and an enhancement in medical expenditure.
The market size for pharmacogenetic testing is projected to experience a significant expansion in the coming years, reaching $25.62 billion by 2029 with an annual compound growth rate of 15.6%. This growth in the projected period can be credited to factors such as increased biotechnology and healthcare research and development, rising healthcare expenses, growing prevalence of chronic diseases, improvements in accessibility, and the growth of telemedicine and digital health. Key trends anticipated during this forecast period involve pharmacogenetic testing, evolution in genomic technologies, technological progression, advancements in companion diagnostics, and groundbreaking diagnostic testing methods.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19139&type=smp
Which Primay Drivers Are Accelerating Growth in the Pharmacogenetic Testing Market?
The surge in demand for personalized medicine is projected to boost the expansion of the pharmacogenetic testing market. Personalized medicine, alternatively known as precision medicine, is a medical model that customizes healthcare choices and treatments based on the unique traits of each patient. The rise in personalized medicine is attributed to factors such as enhanced treatment results, prioritization on early detection and prevention, and cost-efficiency. Pharmacogenetic testing plays a vital role in personalized medicine by examining a person’s genetic composition to anticipate their reaction to specific medications. This allows healthcare professionals to adjust treatments based on genetic variations, maximizing drug effectiveness and reducing harmful side effects. For example, in February 2024, the Personalized Medicine Coalition, a non-profit organization based in the US, stated that the FDA approved 16 innovative personalized treatments for patients with rare diseases in 2023, in contrast to six in 2022. Therefore, the escalating demand for personalized medicine is fueling the development of the pharmacogenetic testing market.
Which Primary Segments of the Pharmacogenetic Testing Market Are Driving Growth and Industry Transformations?
The pharmacogenetic testing market covered in this report is segmented –
1) By Type: Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, Single Gene Tests
2) By Drug Type: Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, Over-The-Counter Medications
3) By Therapeutic Area: Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology And Hypersensitivity, Dermatology, Gynecology, Oncology, Other Therapeutic Areas
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, Direct-to-Customer Services
5) By End User: Healthcare Providers, Pharmaceutical And Biotechnology Companies, Centers And Academic Institutes, Other End Users
Subsegments:
1) By Whole Genome Sequencing: Illumina Sequencing, Ion Torrent Sequencing, Pacific Biosciences Sequencing, Oxford Nanopore Sequencing
2) By Whole Exome Sequencing: Capture-Based Exome Sequencing, Targeted Enrichment Exome Sequencing, Hybridization-Based Exome Sequencing
3) By Array-Based Tests: SNP Array Testing, Expression Array Testing, Copy Number Variation Array Testing
4) By Single Gene Tests: Targeted Gene Panels, Mutation Detection Tests, Sequencing Of Specific Genes
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=19139&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Pharmacogenetic Testing Market?# Market?
Asia-Pacific was the largest region in the pharmacogenetic testing market in 2024 and it is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmacogenetic testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Pharmacogenetic Testing Industry Dynamics?
Key players in the pharmacogenetics testing market are focusing on the creation of advanced pharmacogenomic testing solutions, such as prescription-driven pharmacogenetic testing, to secure a dominant position in the market. Prescription-dependent pharmacogenetic testing is a type of genetic testing that health professionals order specifically to examine a patient’s genetic structure prior to prescribing drugs. For example, in May 2023, the American healthcare firm UCSF launched its own pharmacogenomics testing service crafted to optimize the accuracy of medical therapies. The pharmacogenomics testing service offered by UCSF enables medical practitioners to customize drug treatments based on a person’s genetic makeup, with the goal of increasing drug effectiveness, reducing negative side effects, and bolstering personalized medicine approaches.
View the full report here:
https://www.thebusinessresearchcompany.com/report/pharmacogenetic-testing-global-market-report
What Parameters Are Used to Define the Pharmacogenetic Testing Market?
Pharmacogenetic testing is a type of genetic testing that examines how an individual’s genetic makeup influences their response to specific medications, helping to tailor drug treatments for better efficacy and reduced side effects. This personalized approach enhances patient care by tailoring therapies based on genetic profiles. It is widely used in fields such as oncology, psychology, and cardiology.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19139
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model